1. Home
  2. BCPC vs BIO Comparison

BCPC vs BIO Comparison

Compare BCPC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCPC
  • BIO
  • Stock Information
  • Founded
  • BCPC 1967
  • BIO 1952
  • Country
  • BCPC United States
  • BIO United States
  • Employees
  • BCPC N/A
  • BIO N/A
  • Industry
  • BCPC Major Chemicals
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • BCPC Industrials
  • BIO Industrials
  • Exchange
  • BCPC Nasdaq
  • BIO Nasdaq
  • Market Cap
  • BCPC 5.3B
  • BIO 6.0B
  • IPO Year
  • BCPC N/A
  • BIO N/A
  • Fundamental
  • Price
  • BCPC $156.01
  • BIO $232.99
  • Analyst Decision
  • BCPC Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • BCPC 1
  • BIO 4
  • Target Price
  • BCPC $180.00
  • BIO $324.25
  • AVG Volume (30 Days)
  • BCPC 133.8K
  • BIO 405.4K
  • Earning Date
  • BCPC 07-25-2025
  • BIO 07-31-2025
  • Dividend Yield
  • BCPC 0.55%
  • BIO N/A
  • EPS Growth
  • BCPC 17.80
  • BIO N/A
  • EPS
  • BCPC 4.17
  • BIO N/A
  • Revenue
  • BCPC $964,544,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • BCPC $8.63
  • BIO N/A
  • Revenue Next Year
  • BCPC $6.85
  • BIO $3.49
  • P/E Ratio
  • BCPC $38.32
  • BIO N/A
  • Revenue Growth
  • BCPC 3.76
  • BIO N/A
  • 52 Week Low
  • BCPC $145.70
  • BIO $211.43
  • 52 Week High
  • BCPC $186.03
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • BCPC 30.77
  • BIO 51.88
  • Support Level
  • BCPC $158.47
  • BIO $222.80
  • Resistance Level
  • BCPC $161.10
  • BIO $234.31
  • Average True Range (ATR)
  • BCPC 2.66
  • BIO 7.04
  • MACD
  • BCPC -1.23
  • BIO 1.55
  • Stochastic Oscillator
  • BCPC 0.24
  • BIO 88.43

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: